Advertisement
Advertisement
U.S. markets open in 7 hours 34 minutes
Advertisement
Advertisement
Advertisement
Advertisement

NBEV Dec 2021 1.000 call

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.0500-0.1000 (-66.67%)
As of 03:02PM EST. Market open.
Advertisement
Full screen
Previous Close0.1500
Open0.2200
Bid0.0500
Ask0.2000
Strike1.00
Expire Date2021-12-03
Day's Range0.0500 - 0.2200
Contract RangeN/A
Volume104
Open Interest5
  • GlobeNewswire

    NewAge, Inc. Appoints Judith Hammerschmidt to Board of Directors

    DENVER, Dec. 01, 2021 (GLOBE NEWSWIRE) -- NewAge, Inc. (Nasdaq: NBEV), the Colorado-based direct-to-consumer (D2C) organic and healthy products company, announced today the appointment of Judith Hammerschmidt to its Board of Directors. “Judy has an impressive background having spent many years as outside counsel and as a board member helping companies expand in highly regulated industries,” said Brent Willis, NewAge’s Chief Executive Officer. “We enthusiastically welcome Judy to our Board and lo

  • GlobeNewswire

    NewAge, Inc. to Participate in Roth Capital Deer Valley Conference

    DENVER, Nov. 30, 2021 (GLOBE NEWSWIRE) -- NewAge, Inc. (Nasdaq: NBEV), the Colorado-based direct-to-consumer (D2C) organic and healthy products company, today announced that management will participate in the 10th Annual Roth Capital Deer Valley Conference taking place at the Montage Hotel in Park City, UT on December 9-10, 2021. NewAge CEO Brent Willis and CFO Kevin Manion will host one-on-one meetings with investors at the conference. Interested investors should contact their Roth Capital repr

  • GlobeNewswire

    NewAge Announces New Anti-Aging Discovery and Filing of Patent on New Formula

    DENVER, Nov. 16, 2021 (GLOBE NEWSWIRE) -- NewAge, Inc. (Nasdaq: NBEV), the Colorado-based direct-to-consumer (D2C) organic and healthy products company, today announced the discovery of a new method of action to fight the effects of aging and the filing of a new patent to protect the uniqueness of the discovery. Following publication in the Journal of Biosciences and Medicine of the recent discovery on how to block spike proteins from binding to human cells, NewAge scientists have filed for a pa

Advertisement
Advertisement